Biora Therapeutics (BIOR) Misses Q3 EPS by 504c

Biora Therapeutics (NASDAQ: BIOR) reported Q3 EPS of ($5.04). Revenue for the quarter came in at $30 thousand.

For earnings history and earnings-related data on Biora Therapeutics (BIOR) click here.

You May Also Be Interested In

• AI and memory not a classic bubble, but future returns uncertain - strategist
• Dollar General (DG) 928 contracts of December 150 calls trade, share price up 2.1%
• Dropbox (DBX) October 9 weekly 33 puts active, share price down 4.5%